New and Emerging Therapeutic Options for the Treatment of Actinic Keratosis

RECORDED: January 26th at 6:15am HST (8:15am PST, 11:15am EST)

Chair: George Martin, MD; Dermatology Associates; Kihei, HI

Panelist: Orit Markowitz, MD; Icahn School of Medicine at Mount Sinai; New York, NY

Panelist: Theodore Rosen, MD; Baylor College of Medicine; Houston, TX

Valid for credit through: January 26, 2022

Originally presented at MauiDerm 2021

Target Audience and Activity Goal

This activity is intended for dermatologists involved in the management of patients with actinic keratosis (AK).

The goal of this activity is to provide an update on the assessment and prognosis, as well as the role of current and emerging therapeutic agents for the management of AK.

After successful completion of this activity, participants should be better able to:

Assess and identify patients that may benefit from earlier treatment of AK
Evaluate the prognosis of AK
Describe the short- and long-term goals of treatment for AK
Outline both the benefits and limitations of currently available treatment strategies for AK
Evaluate the safety and efficacy profiles of current and emerging treatment options for AK
Assess evidence-based data to inform clinical decision-making when selecting treatment
Adopt preventative measures for patients with chronic AK

Supported by an independent educational grant from Almirall

Credits Available

NACCME designates this internet enduring activity for a maximum of 1 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures

Springer Healthcare, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Faculty

George Martin, MD

Medical Director
Dermatology Associates
Kihei, HI

Disclosure: George Martin, MD, has disclosed the following relevant financial relationships: Served as an advisor or consultant for: Almirall, Athenex, Bristol Myers Squibb, Celgene, Galderma, Horizon, Janssen, LEO, Lilly, Ortho/Bausch, Pfizer, SUN/DUSA, UCB.

Orit Markowitz, MD

Medical Director
Founder OptiSkin
New York, NY

Associate Clinical Professor of Dermatology, Downstate Medical Center, Brooklyn, NY

Mt. Sinai Medical Center, New York, NY

Disclosure: Orit Markowitz, MD, has disclosed the following relevant financial relationships: Served as an advisor or consultant for: Dermtech, Heine, LEO, Regeneron.

Theodore Rosen, MD

Professor of Dermatology
Baylor College of Medicine
Houston, TX

Chief of Dermatology Service, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX

Disclosure: Theodore Rosen, MD, has disclosed the following relevant financial relationships: Served as an advisor or consultant for: Almirall, Beiesdorf, Derm Tech, Foamix, Galderma, and Menlo Pharmaceuticals.

Editor

Elizabeth Samander, PhD

Medical Director, Springer Healthcare

Disclosure: Elizabeth Samander has disclosed no relevant financial relationships.

CME Editors

Randy Robbin

President, NACCME, LLC

Greaton Sellers

Associate Director, Accreditation and Compliance, NACCME, LLC.

NACCME, LLC staff have disclosed that they have no relevant financial relationships.

Springer Healthcare, LLC staff have disclosed that they have no relevant financial relationships.

Disclosures

In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and Springer Healthcare. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

NACCME designates this internet enduring activity for a maximum of 1 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME activity noted above. For technical assistance, contact simon.fry@springer.com.

Instructions For Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within one hour; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit^TM, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives and author disclosures.
Complete the pre-test.
To successfully complete the activity view the video presentations, then complete the online post-test by choosing the best answer to each question. The post-test will automatically be graded.
You must successfully complete the post-test with a score of 75% or higher to proceed to the evaluation and obtain your certificate.
If you receive a score of 74% or less, you may retake the post-test until successful.
Your certificate will be made available immediately upon successful completion.

Originally presented at MauiDerm 2021

Target Audience and Activity Goal

After successful completion of this activity, participants should be better able to:

Credits Available

Disclosures